Microduplications of ARID1A and ARID1B cause a novel clinical and epigenetic distinct BAFopathy

Pleuntje J van der Sluijs, Sébastien Moutton, Alexander J M Dingemans, Denisa Weis, Michael A Levy, Kym M Boycott, Claudia Arberas, Margherita Baldassarri, Claire Beneteau, Alfredo Brusco, Charles Coutton, Tabib Dabir, Maria L Dentici, Koenraad Devriendt, Laurence Faivre, Mieke M van Haelst, Khadije Jizi, Marlies J Kempers, Jennifer Kerkhof, Mira KharbandaKatherine Lachlan, Nathalie Marle, Haley McConkey, Maria A Mencarelli, David Mowat, Marcello Niceta, Claire Nicolas, Antonio Novelli, Valeria Orlando, Olivier Pichon, Julia Rankin, Raissa Relator, Fabienne G Ropers, Jill A Rosenfeld, Rani Sachdev, Sarah A Sandaradura, Elena Shukarova-Angelovska, Duco Steenbeek, Marco Tartaglia, Matthew A Tedder, Slavica Trajkova, Norbert Winer, Jeremy Woods, Bert B A de Vries, Bekim Sadikovic, Marielle Alders, Gijs W E Santen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose: ARID1A/ARID1B haploinsufficiency leads to Coffin-Siris syndrome, duplications of ARID1A lead to a distinct clinical syndrome, whilst ARID1B duplications have not yet been linked to a phenotype. Methods: We collected patients with duplications encompassing ARID1A and ARID1B duplications. Results: 16 ARID1A and 13 ARID1B duplication cases were included with duplication sizes ranging from 0.1 to 1.2 Mb (1-44 genes) for ARID1A and 0.9 to 10.3 Mb (2-101 genes) for ARID1B. Both groups shared features, with ARID1A patients having more severe intellectual disability, growth delay, and congenital anomalies. DNA methylation analysis showed that ARID1A patients had a specific methylation pattern in blood, which differed from controls and from patients with ARID1A or ARID1B loss-of-function variants. ARID1B patients appeared to have a distinct methylation pattern, similar to ARID1A duplication patients, but further research is needed to validate these results. Five cases with duplications including ARID1A or ARID1B initially annotated as duplications of uncertain significance were evaluated using PhenoScore and DNA methylation reanalysis, resulting in the reclassification of 2 ARID1A and 2 ARID1B duplications as pathogenic. Conclusion: Our findings reveal that ARID1B duplications manifest a clinical phenotype, and ARID1A duplications have a distinct episignature that overlaps with that of ARID1B duplications, providing further evidence for a distinct and emerging BAFopathy caused by whole-gene duplication rather than haploinsufficiency.

Original languageEnglish
Article number101283
JournalGenetics in Medicine
Volume27
Issue number1
Early online date28 Sept 2024
DOIs
Publication statusE-pub ahead of print - 28 Sept 2024

Keywords

  • ARID1A
  • ARID1B
  • BAF-complex
  • Intellectual Disability
  • duplication

Fingerprint

Dive into the research topics of 'Microduplications of ARID1A and ARID1B cause a novel clinical and epigenetic distinct BAFopathy'. Together they form a unique fingerprint.

Cite this